<DOC>
	<DOCNO>NCT01412918</DOCNO>
	<brief_summary>To evaluate effectiveness Inhibitor™ Tinnitus Masking Device . To determine high incident expression sodium channel , voltage gate , type IX alpha subunit ( SCN9 ) gene subject disturb tinnitus subject disturb tinnitus .</brief_summary>
	<brief_title>Inhibitor Masking Device &amp; Sodium Channel , Voltage Gated , Type IX Alpha Subunit ( SCN9 ) Gene Expression</brief_title>
	<detailed_description>Up 50 million Americans tinnitus regular basis 2-3 million suffering tinnitus affect daily living . The Inhibitor™ Tinnitus Masking Device new tinnitus treatment device recently available United States use temporary relief tinnitus . The device emit ultra high frequency sound 60 second via bone conduction apply mastoid . Patients report tinnitus provide opportunity demonstrate device observe change tinnitus . The device may demonstrate 5 time . The investigator record degree duration change tinnitus perception follow treatment Inhibitor™ Tinnitus Masking Device . Patients may provide genetic sample ( typically via saliva sample ) look expression particular genetic marker may associate tinnitus . The investigator collect sample people tinnitus without tinnitus use control .</detailed_description>
	<mesh_term>Tinnitus</mesh_term>
	<criteria>18 year , tinnitus Pacemaker , pregnancy , metal implant head neck , thrombosis , migraines/headaches , metal bond retainer , surgery within last 6 month patient still recover , medical reason physician would advise use device , 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Tinnitus</keyword>
	<keyword>Inhibitor Device</keyword>
	<keyword>SCN9 gene</keyword>
	<keyword>Ringing ear</keyword>
	<keyword>Milwaukee</keyword>
	<keyword>Medical College Wisconsin</keyword>
</DOC>